Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice-Reference-Cited by-同舟云学术

Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice

Published:2019-10-21 Issue:8 Volume:104 Page:1686-1694
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Cucchiari David,Molina-Andujar Alicia,Montagud-Marrahi Enrique,Revuelta Ignacio,Rovira Jordi,Ventura-Aguiar Pedro,Piñeiro Gastón J.,De Sousa-Amorim Erika,Esforzado Nuria,Cofán Frederic,Torregrosa Jose-Vicente,Ugalde-Altamirano Jessica,Ricart M. José,Centellas-Pérez Francisco J.,Solè Manel,Martorell Jaume,Ríos José,Campistol Josep M.,Diekmann Fritz,Oppenheimer Frederic

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference32 articles.

1. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.;Sellarés;Am J Transplant,2012

2. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.;Lebranchu;Am J Transplant,2002

3. Disassociation between risk of graft loss and risk of non-hodgkin lymphoma with induction agents in renal transplant recipients.;Opelz;Transplantation,2006

4. Recommendations for the use of everolimus in de novo kidney transplantation: false beliefs, myths and realities.;Pascual;Nefrologia,2017

5. Reduced exposure to calcineurin inhibitors in renal transplantation.;Ekberg;N Engl J Med,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Everolimus plus reduced calcineurin inhibitor prevents de novo anti-HLA antibodies and humoral rejection in kidney transplant recipients: 12-month results from the ATHENA study;Frontiers in Transplantation;2023-10-27

2. Medical Aspects of mTOR Inhibition in Kidney Transplantation;International Journal of Molecular Sciences;2022-07-12

3. Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series;Journal of Clinical Apheresis;2021-12-22

4. An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients;Transplantation Reviews;2021-09

5. Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient;Journal of Clinical Medicine;2021-08-18